To investigate the efficacy and safety of add‐on anakinra for severe Still's disease complicated by macrophage activation syndrome (MAS) in a real‐world setting.
Jia-Xian Guo, Hao-Jie Xu, Wei-Wei Li et al.· International Journal of Rhe...· 0 citations
OBJECTIVES
To evaluate the real-world effectiveness and safety of tocilizumab (TCZ) in glucocorticoid (GC)-resistant adult-onset Still's disease (AOSD) and explore predictors of clinical response.
METHODS
This prospective, single-centre cohort study enrolled consecutive eligible patients with GC-resistant AOSD who in...
Dou-Dou Ma, Hai-Hong Yao, Xia Zhang et al.· Clinical and Experimental Rh...· 0 citations
Current evidence on TCR and BCR repertoire alterations across major autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren's disease, type 1 diabetes, and ankylosing spondylitis is synthesized.
Xin-Miao Wang, Hua-Qun Zhu, Zhan-Guo Li et al.· Autoimmunity Reviews· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.